Lantern Pharma Inc.
LTRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7,511 | $21,938 | $37,202 | $51,524 |
| Short-Term Investments | $16,502 | $19,365 | $17,994 | $19,201 |
| Receivables | $0 | $860 | $0 | $181 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,235 | $1,179 | $3,527 | $1,810 |
| Total Curr. Assets | $25,248 | $43,341 | $58,723 | $72,716 |
| Property Plant & Equip (Net) | $287 | $280 | $96 | $216 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $1,000 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $37 | $26 | $18 | $18 |
| Total NC Assets | $324 | $306 | $114 | $1,234 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $25,572 | $43,648 | $58,836 | $73,950 |
| Liabilities | – | – | – | – |
| Payables | $0 | $942 | $0 | $2,174 |
| Short-Term Debt | $191 | $173 | $53 | $152 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4,140 | $1,563 | $2,745 | $0 |
| Total Curr. Liab. | $4,331 | $2,678 | $2,798 | $2,326 |
| LT Debt | $53 | $61 | $0 | $53 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $53 | $61 | $0 | $53 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $244 | $234 | $53 | $53 |
| Total Liabilities | $4,384 | $2,740 | $2,798 | $2,379 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$76,026 | -$55,244 | -$39,283 | -$25,023 |
| AOCI | $154 | -$107 | -$371 | -$93 |
| Other Equity | $97,058 | $96,259 | $95,691 | $96,686 |
| Total Equity | $21,188 | $40,908 | $56,038 | $71,571 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $25,572 | $43,648 | $58,836 | $73,950 |
| Net Debt | -$7,267 | -$21,703 | -$37,149 | -$51,319 |